Treatment Recommendations for Psychedelic-assisted Therapy

Abstract

Switzerland's early contributions to the 'psychedelic renaissance', the revival of psychedelic science starting in the early 21st century, might be particularly noteworthy given the growing global interest in using psychedelics for research and therapy.In 2023, the Swiss Interest Group for Psychedelic-assisted Therapy was established to provide a clear and widely accepted framework for work related to psychedelic-assisted therapy.Members of this group created a first draft of treatment recommendations (S1 guidelines).These recommendations will be continuously updated to incorporate new findings in research and therapy.